Xenomics, a developer of next-generation medical DNA technologies, announced
today that a team of company scientists has contributed a chapter about the
Xenomics' proprietary transrenal DNA technology platform in a new edition of
a leading scientific textbook about key advances and topics in the field of
modern molecular diagnostic advancements.